Management of Stable Angina with Ivabradine as Safe Alternative to Patients with Myasthenia Gravis

Figure 2

(a) Graphic shows QMG, MG-ADL, and CCS scores before and during the initial 12 months of therapy. (b) Graphic shows 6-MWT scores before and during the initial 4 weeks of therapy. (QMG: Quantitative Myasthenia Gravis test; MG-ADL: Myasthenia Gravis-specific Activities of Daily Living scale; CCS: Canadian Cardiovascular Society grading of angina pectoris; 6-MWT: 6-minute walking test.)

(a)

(b)